about
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience...
Read More
3.58
-0.07
(-1.92%)
977.6K
XNAS Volume
XNAS 22 Sep, 2026 12:36 PM (EDT)
Board Meeting
The next board meeting for Inventiva (ADR) is on 30 Sep 2026 for the purpose of Stifel 2026 Virtual Cardiometabolic Forum
See details
Not Eligible
Expensive Valuation
Technically Bearish
Inventiva (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..